These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 3121978)

  • 1. [Immunobiological characterization of a presumed atypical strain of Trypanosoma cruzi].
    Muller LA; de Isola EL; Quintana RD; González Cappa SM
    Medicina (B Aires); 1987; 47(2):139-44. PubMed ID: 3121978
    [No Abstract]   [Full Text] [Related]  

  • 2. Suppression of antibody dependent cytotoxicity to Trypanosoma cruzi in chronic chagasic mice after treatment with nifurtimox.
    Chambó JG; Cabeza Meckert PM; Laguens RP
    Medicina (B Aires); 1988; 48(1):49-53. PubMed ID: 3146009
    [No Abstract]   [Full Text] [Related]  

  • 3. [Exoantigens of Trypanosoma cruzi. Epitopes reactive against immunoglobulins of patients with Chagas' disease].
    Gruppi A; Moretti ER; Basso B; Vottero-Cima E
    Medicina (B Aires); 1988; 48(2):161-6. PubMed ID: 3148093
    [No Abstract]   [Full Text] [Related]  

  • 4. Biological characterization of Trypanosoma cruzi stocks from Chilean insect vectors.
    Solari A; Wallace A; Ortiz S; Venegas J; Sanchez G
    Exp Parasitol; 1998 Jul; 89(3):312-22. PubMed ID: 9676709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strain specific protective immunity against Trypanosoma cruzi.
    Kloetzel JK; Lafaille JJ
    J Parasitol; 1983 Apr; 69(2):267-70. PubMed ID: 6406657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of chagas infection caused by an atypical strain of Trypanosoma cruzi in a newborn infant].
    de Storni P; Bakos E; Bustamante A; Vanioff JA
    Medicina (B Aires); 1984; 44(3):287-91. PubMed ID: 6443628
    [No Abstract]   [Full Text] [Related]  

  • 7. Trypanosoma rangeli: epimastigote immunogenicity and cross-reaction with Trypanosoma cruzi.
    Saldaña A; Sousa OE
    J Parasitol; 1996 Apr; 82(2):363-6. PubMed ID: 8604121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A simple model for the interaction between T. cruzi and its antibodies during Chagas infection.
    Isasi SC; Sibona GJ; Condat CA
    J Theor Biol; 2001 Jan; 208(1):1-13. PubMed ID: 11162048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunoprotection in rats by cultured epimastigotes of Trypanosoma cruzi].
    Rodríguez AM; Afchain D; Rivera-Vanderpas MT; Bazin H; Capron A
    Medicina (B Aires); 1983; 43(4):383-90. PubMed ID: 6419005
    [No Abstract]   [Full Text] [Related]  

  • 10. Trypanocidal activity of 4 isopropyl salicylaldehyde and 4-isopropyl salicylic acid on Trypanosoma cruzi.
    Nogueda-Torres B; Rodríguez-Paez L; Ramírez IB; Ramírez CW
    Rev Latinoam Microbiol; 2001; 43(1):1-6. PubMed ID: 17061565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production and characterization of clones of the Brazil strain of Trypanosoma cruzi.
    Murfin DJ; Choromanski L; Kuhn RE
    J Parasitol; 1985 Oct; 71(5):525-9. PubMed ID: 3932632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental Chagas' disease in mice infected with one LD50 of parasite.
    Repka D; Rangel HA; Atta AM; Gavino VA; Piedrabuena AE
    Rev Bras Biol; 1985 Aug; 45(3):309-16. PubMed ID: 3938552
    [No Abstract]   [Full Text] [Related]  

  • 13. [Trypanosoma cruzi pathology. Strain dependent?].
    Gonzalez Cappa SM; Mirkin GA; Solana ME; Tekiel VS
    Medicina (B Aires); 1999; 59 Suppl 2():69-74. PubMed ID: 10668246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Influence of the age of a rat on the course of infection with Trypanosoma cruzi].
    Revelli S; Moreno H; Berra H; Valenti JL; Lía Nocito A; Amerio N; Morini JC
    Medicina (B Aires); 1987; 47(4):360-6. PubMed ID: 3133534
    [No Abstract]   [Full Text] [Related]  

  • 15. Trypanosoma cruzi: impact of clonal evolution of the parasite on its biological and medical properties.
    Revollo S; Oury B; Laurent JP; Barnabé C; Quesney V; Carrière V; Noël S; Tibayrenc M
    Exp Parasitol; 1998 May; 89(1):30-9. PubMed ID: 9603486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Characterization of Trypanosoma cruzi strains isolated from patients with heart transplantation].
    Lahura PN; Matsubara L; Amato Neto V; Okumura M; Bocchi EA
    Rev Hosp Clin Fac Med Sao Paulo; 1995; 50(2):97-100. PubMed ID: 7569603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of membrane-bound IgM in Trypanosoma cruzi evasion from immune clearance.
    Garcia IE; Lima MR; Marinho CR; Kipnis TL; Furtado GC; Alvarez JM
    J Parasitol; 1997 Apr; 83(2):230-3. PubMed ID: 9105302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Etiological treatment of Chagas' disease].
    Rassi A
    Arq Bras Cardiol; 1982 Apr; 38(4):277-81. PubMed ID: 6820273
    [No Abstract]   [Full Text] [Related]  

  • 19. Further genetic characterization of the two Trypanosoma cruzi Berenice strains (Be-62 and Be-78) isolated from the first human case of Chagas disease (Chagas, 1909).
    Cruz RE; Macedo AM; Barnabé C; Freitas JM; Chiari E; Veloso VM; Carneiro CM; Bahia MT; Tafuri WL; Lana M
    Acta Trop; 2006 Mar; 97(3):239-46. PubMed ID: 16343412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity of Trypanosoma cruzi strains determined by neutralization test.
    Muller LA; González Cappa SM
    Rev Argent Microbiol; 1987; 19(3):101-7. PubMed ID: 3140292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.